I only feel comfortable suggesting an RCT of routine vaccines because I am confident it wouldn't get off the ground.

The New Normal Five years ago, COVID-19 was declared a global pandemic, marking the official onset of a healthcare crisis ...

Manually producing the TLF involves an interplay of biostatisticians, terminology coders, statistical programmers, and ...

Effective drug discovery and development hinge on high-quality data. Implementing FAIR principles enhances data usability and ...

Targeted chemotherapy in the abdomen using a technique called PIPAC combined with systemic standard-of-care chemotherapy is shown to be safe, with promising activity for patients with colorectal and a ...

VERITAC-2 achieved its primary endpoint in the estrogen receptor 1-mutant population, demonstrating statistically significant and clinically ...

Innovation, collaboration, and regulatory reform were on the agenda at the 2025 Clinical Trial Supply Europe conference.

Scientific literature has increased at a rate of 8-9% annually since 1980, doubling every decade and creating an information ...

IQVIA (NYSE:IQV), a leading global provider of AI-powered analytics, technology solutions and clinical research services to the healthcare and life sc ...

Recent research throws into question whether GLP-1 drugs increase the risk of certain types of thyroid cancer.

A modified herpes virus that targets spinal cord nerve cells to treat neurogenic bladder in people with spinal cord injury is underway in a first-in-human clinical trial by UTHealth Houston at ...

Raghava's research has been broadly accepted in peer-reviewed journals, industry conferences, and regulatory discussions.